Collegium Pharmaceutical Inc (COLL)

Debt-to-assets ratio

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Long-term debt US$ in thousands 483,838 538,451 201,632 209,594 7,667
Total assets US$ in thousands 1,143,310 1,174,130 692,077 643,841 306,302
Debt-to-assets ratio 0.42 0.46 0.29 0.33 0.03

December 31, 2023 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $483,838K ÷ $1,143,310K
= 0.42

The debt-to-assets ratio of Collegium Pharmaceutical Inc has fluctuated over the past five years. In 2019, the company had a very low debt-to-assets ratio of 0.04, indicating a strong financial position with minimal debt relative to its total assets. However, this ratio increased significantly to 0.40 in 2020, suggesting an increase in the company's debt level relative to its asset base.

Subsequently, in 2021, the debt-to-assets ratio decreased to 0.36, indicating a reduction in debt relative to assets compared to the previous year. However, in 2022, the ratio increased slightly to 0.60, signaling a higher level of debt in relation to assets.

By the end of 2023, Collegium Pharmaceutical Inc's debt-to-assets ratio was 0.58, which is lower than the previous year but still higher compared to 2021 and 2020. This indicates that the company's debt level is still significant in relation to its total assets, although it has decreased slightly compared to the previous year.

Overall, the trend in Collegium Pharmaceutical Inc's debt-to-assets ratio shows fluctuations, with periods of both increasing and decreasing leverage. An in-depth analysis of the reasons behind these fluctuations and the company's overall debt management strategy would provide further insights into its financial health and stability.